Manolis, Antonis A <br/><br/>
Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives.  [electronic resource] 

 -  Vascular health and risk management  2019 
 - 571-579 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1178-2048 
<br/><br/><label>Standard No.: </label>10.2147/VHRM.S210150  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Clinical Decision-Making<br/>Diuretics--administration & dosage<br/>Dosage Forms<br/>Drug Compounding<br/>Flavoring Agents--administration & dosage<br/>Heart Failure--diagnostic imaging<br/>Humans<br/>Mineralocorticoid Receptor Antagonists--administration & dosage<br/>Patient Selection<br/>Risk Factors<br/>Spironolactone--administration & dosage<br/>Treatment Outcome